* Nationwide Vaccination Camps At Around 100 Centers; Rabies Accounts For 90% of Zoonotic Cases In India
Indian Immunologicals Limited (IIL), one of India's leading biotechnology companies dedicated to manufacturing and supplying life-saving vaccines, commemorated World Zoonoses Day. This significant occasion highlights the urgent need for global attention and collaborative efforts to combat zoonotic diseases and safeguard public health. On World Zoonoses Day, Indian Immunologicals Limited has organized “Free Anti-rabies Vaccination Camps” across India. One Lakh doses of Anti-rabies vaccine were administered free of cost with leading brands- Raksharab and Starvac R in as many as 100 cities across the country through veterinary dispensaries, veterinary colleges and NGOs.
Zoonoses is infectious diseases transmitted between animals and humans, pose a persistent threat to global health security. As the world faces the challenges of emerging zoonotic outbreaks, IIL reiterates its unwavering commitment to protecting human lives through preventive measures, research, and vaccine development.
Over the years, IIL has emerged as a frontrunner in vaccine production, consistently contributing to disease prevention and control. Through relentless dedication to research and innovation, IIL has developed and manufactured vaccines for various zoonotic diseases such as rabies, brucellosis etc. These vaccines have played a crucial role in preventing the spread of these diseases, safeguarding countless lives in India and beyond.
About Indian Immunologicals Limited (IIL)
Indian Immunologicals Limited headquartered in Hyderabad, India is one of the largest producers of vaccines in Asia. IIL was set up by National Dairy Development Board (NDDB) in 1982. IIL has multiple GMP manufacturing sites and exports to over 50 countries. IIL has a strong R&D pipeline and has launched several animals and human vaccines in the Indian market at affordable prices. IIL specializes in the development of various types of vaccines ranging from inactivated and live viral vaccines, polysaccharide conjugate vaccines, recombinant subunit vaccines, toxoid vaccines, and live bacterial vaccines. More details about the company can be viewed at www.indimmune.com.